Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling
- PMID: 26109563
- DOI: 10.1002/art.39214
Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling
Abstract
Objective: Autoantibodies are highly characteristic of primary Sjögren's syndrome (SS) and represent important tools for studying its pathogenesis. Nonetheless, thus far, no systematic investigations have assessed the presence of autoantibodies before diagnosis. This study was undertaken to analyze how early and in what order autoantibodies appear, how predictive they are of primary SS, and whether they identify disease subsets.
Methods: A nested case-control design linking data from the Malmö primary SS registry and 3 Swedish healthcare biobanks was applied. In all, 175 serum samples obtained from 117 individuals before diagnosis of primary SS and 1 serum sample from each of 117 matched controls were analyzed for antinuclear antibodies (ANAs), rheumatoid factor (RF), and antibodies against Ro 60/SSA, Ro 52/SSA, and La/SSB.
Results: Considering all patients with primary SS who were autoantibody positive after diagnosis, at least one autoantibody specificity was detected in 81% up to 20 years (median 4.3-5.1 years) before diagnosis. Those found most often were ANAs, followed by RF, anti-Ro 60/SSA, anti-Ro 52/SSA, and anti-La/SSB. Anti-Ro/SSA and anti-La/SSB antibodies were strongly associated with the risk of developing primary SS, especially early-onset disease and a severe disease course. When Bayesian prior prevalence estimates for primary SS were included in the calculation, prediagnostic anti-Ro 60/SSA and anti-Ro 52/SSA had the highest positive predictive values (25% and 100%, respectively).
Conclusion: Our findings indicate that autoantibodies are present for up to 18-20 years before the diagnosis of primary SS, but we cannot exclude even earlier seropositivity, since for most patients, the earliest sample analyzed was positive. In families with multiple cases of autoimmune disease, autoantibody profiling, along with assessment of genetic risk, enables identification of susceptible individuals in a predisease state.
© 2015, American College of Rheumatology.
Comment in
-
Positive Findings on an Early Autoantibody Panel in Sjögren's Syndrome Often Predate Positive Findings on Classic Tests: Comment on the Article by Theander et al.Arthritis Rheumatol. 2016 Aug;68(8):2054-5. doi: 10.1002/art.39705. Arthritis Rheumatol. 2016. PMID: 27059087 No abstract available.
-
Reply.Arthritis Rheumatol. 2016 Aug;68(8):2055-6. doi: 10.1002/art.39702. Arthritis Rheumatol. 2016. PMID: 27059925 No abstract available.
Similar articles
-
Predicting Sjögren's syndrome in patients with recent-onset SLE.Rheumatology (Oxford). 2013 Aug;52(8):1438-42. doi: 10.1093/rheumatology/ket141. Epub 2013 Apr 16. Rheumatology (Oxford). 2013. PMID: 23594470
-
Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.Egypt J Immunol. 2004;11(1):75-81. Egypt J Immunol. 2004. PMID: 15724389
-
Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.Clin Exp Rheumatol. 2012 Sep-Oct;30(5):686-92. Epub 2012 Oct 17. Clin Exp Rheumatol. 2012. PMID: 22704838
-
Autoantibodies, detection methods and panels for diagnosis of Sjögren's syndrome.Clin Immunol. 2017 Sep;182:24-29. doi: 10.1016/j.clim.2017.03.017. Epub 2017 Apr 5. Clin Immunol. 2017. PMID: 28390965 Review.
-
The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.Adv Ther. 2017 Apr;34(4):799-812. doi: 10.1007/s12325-017-0501-3. Epub 2017 Mar 10. Adv Ther. 2017. PMID: 28283891 Review.
Cited by
-
Ro60-Roles in RNA Processing, Inflammation, and Rheumatic Autoimmune Diseases.Int J Mol Sci. 2024 Jul 14;25(14):7705. doi: 10.3390/ijms25147705. Int J Mol Sci. 2024. PMID: 39062948 Free PMC article. Review.
-
Advances in cellular and molecular pathways of salivary gland damage in Sjögren's syndrome.Front Immunol. 2024 Jul 10;15:1405126. doi: 10.3389/fimmu.2024.1405126. eCollection 2024. Front Immunol. 2024. PMID: 39050857 Free PMC article. Review.
-
Exploring Salivary Epithelial Dysfunction in Sjögren's Disease.Int J Mol Sci. 2024 May 2;25(9):4973. doi: 10.3390/ijms25094973. Int J Mol Sci. 2024. PMID: 38732189 Free PMC article. Review.
-
Age-associated B cell infiltration in salivary glands represents a hallmark of Sjögren's-like disease in aging mice.Geroscience. 2024 Apr 24. doi: 10.1007/s11357-024-01159-3. Online ahead of print. Geroscience. 2024. PMID: 38656650
-
Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögren's syndrome and Sicca.RMD Open. 2024 Apr 10;10(2):e003666. doi: 10.1136/rmdopen-2023-003666. RMD Open. 2024. PMID: 38599651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials